Market-Moving News May 2nd
Market-Moving News May 2nd
5月2日市场动向新闻
ALLR: 151% | Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical benefit, leading to early conclusion of the Phase 2 trial in advanced ovarian cancer.
ALLR：151％ | Allarity Therapeutics的股价走高，此前该公司宣布Stenoparib显示出明显的临床益处，导致晚期卵巢癌的2期试验提前结束。
LUNG: 29% | Pulmonx shares are trading higher after the company reported better-than-expected Q1 financial results.
肺部：29％ | Pulmonx公布的第一季度财务业绩好于预期后，该公司股价走高。
EBS: 83% | Emergent Biosolutions shares are trading higher after the company announced operational changes to stabilize its financial position and reported Q1 financial results.
EBS：83% | Emergent Biosolutions的股价走高，此前该公司宣布了运营调整以稳定其财务状况并公布了第一季度财务业绩。